Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases?

被引：0
|
作者：
Genecand, Leon [1 ]
Lador, Frederic [1 ]
Montani, David [2 ]
Perneger, Thomas [3 ,4 ]
机构：
[1] Univ Hosp Geneva, Dept Med, Div Pneumol, Geneva, Switzerland
[2] Univ Paris Saclay, Hop Bicetre, Pulm Hypertens Natl Referral Ctr, AP AP,Dept Resp & Intens Care Med,INSERM,UMR S 999, Gif Sur Yvette, France
[3] Univ Geneva, Dept Hlth & Community Med, Div Clin Epidemiol, Geneva, Switzerland
[4] Univ Hosp Geneva, Geneva, Switzerland
来源：
CHEST | 2024年 / 165卷 / 05期
关键词：
D O I：
10.1016/j.chest.2023.12.032
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：e161 / e161
页数：1
相关论文
共 50 条
  • [1] Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases? Response
    Nathan, Steven D.
    Shen, Eric
    Deng, Chunqin
    CHEST, 2024, 165 (05) : e162 - e162
  • [2] Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
    Waxman, Aaron
    Restrepo-Jaramillo, Ricardo
    Thenappan, Thenappan
    Ravichandran, Ashwin
    Engel, Peter
    Bajwa, Abubakr
    Allen, Roblee
    Feldman, Jeremy
    Argula, Rahul
    Smith, Peter
    Rollins, Kristan
    Deng, Chunqin
    Peterson, Leigh
    Bell, Heidi
    Tapson, Victor
    Nathan, Steven D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (04): : 325 - 334
  • [3] Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease
    Faria-Urbina, Mariana
    Oliveira, Rudolf K. F.
    Agarwal, Manyoo
    Waxman, Aaron B.
    LUNG, 2018, 196 (02) : 139 - 146
  • [4] Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease
    Mariana Faria-Urbina
    Rudolf K. F. Oliveira
    Manyoo Agarwal
    Aaron B. Waxman
    Lung, 2018, 196 : 139 - 146
  • [5] DOSE RESPONSE ANALYSIS OF INHALED TREPROSTINIL IN PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND ITS EFFECTS ON CLINICAL WORSENING
    Waxman, Aaron
    Nathan, Steven
    Fisher, Micah
    Ford, H. James
    Gagermeier, James
    Parambil, Joseph
    Raina, Amresh
    Zwicke, Dianne
    Gerke, Alicia
    Shen, Eric
    Lee, Dasom
    Rao, Youlan
    Tapson, Victor
    CHEST, 2021, 160 (04) : 2279A - 2280A
  • [6] Inhaled treprostinil for pulmonary hypertension
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 (2): : 64 - 65
  • [7] Vasoreactivity and inhaled treprostinil response in interstitial lung disease pulmonary hypertension
    Harder, Eileen M.
    Rahaghi, Farbod N.
    Leopold, Jane A.
    Systrom, David M.
    Washko, George R.
    Waxman, Aaron B.
    ERJ OPEN RESEARCH, 2024, 10 (06)
  • [8] Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension
    Parikh, Kishan S.
    Rajagopal, Sudarshan
    Fortin, Terry
    Tapson, Victor F.
    Poms, Abby D.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2016, 67 (04) : 322 - 325
  • [9] COMPARISON OF EFFECTS OF INHALED TREPROSTINIL ON LUNG FUNCTION IN PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND PULMONARY ARTERIAL HYPERTENSION
    Nathan, Steven
    Tapson, Victor
    Ramani, Gautam
    Medarov, Boris
    Levine, Deborah
    Burger, Charles
    El-Kersh, Karim
    Shen, Eric
    Rao, Youlan
    Smith, Peter
    Waxman, Aaron
    CHEST, 2021, 160 (04) : 2244A - 2246A
  • [10] Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease
    Sakao, Seiichiro
    Kondoh, Yasuhiro
    Kinoshita, Hideyuki
    Nishiyama, Osamu
    Ogo, Takeshi
    Tanabe, Nobuhiro
    Minatsuki, Shun
    Nakayama, Kazuhiko
    Taniguchi, Yu
    Takahashi, Kenta
    Takatsu, Masahiro
    Ogura, Takashi
    RESPIRATORY INVESTIGATION, 2024, 62 (06) : 980 - 986
12345